Use of R-arylpropionic acids for treating illnesses with a rheumatic nature
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 10, 2012
Grant Date -
Feb 26, 2004
app pub date -
Sep 24, 2001
filing date -
Sep 25, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to the use of R-enantiomers of arylpropionic acids or the pharmacologically acceptable salts or derivatives thereof, in a pure or enriched form in contrast to the racemic compound, for the production of medicaments which inhibit the activation of nuclear transcription factor AP-1 and which are suitable for treating illnesses which are influenced by said factor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully